REGENEREX PHARMA, INC. 8-K

What Happened
Regenerex Pharma, Inc. (RGPX) announced in a Form 8-K filed June 11, 2026 (Item 5.02) that it commenced legal proceedings on June 5, 2026 against its former Chief Financial Officer, Kenneth W. Perry. The suit — Regenerex Pharma, Inc. v. Kenneth W. Perry — is pending in Smith County Chancery Court, Case No. 2026-CV-8813. The company says it is seeking recovery of funds and other amounts it alleges are owed, plus additional relief related to the former CFO’s conduct while employed by the company.

Key Details

• Filing date (Form 8-K): June 11, 2026; complaint filed/commenced: June 5, 2026.
• Defendant/former officer: Kenneth W. Perry, former Chief Financial Officer.
• Court and case: Smith County Chancery Court, Case No. 2026-CV-8813.
• Remedies sought: monetary damages, restitution, disgorgement (where applicable), injunctive relief, costs, and other equitable relief. A litigation update dated June 5, 2026 was filed as an exhibit.

Why It Matters
This is a governance and legal development that could affect the company’s finances and management stability. The complaint seeks recovery of funds and other remedies that, if successful, could benefit Regenerex’s financial position; however, the allegations are subject to judicial determination and the company gave no assurance of the outcome. Investors should note the added legal uncertainty and monitor future filings for case developments, potential expenses, or any disclosed financial impact.